Reduction in Fatigue in Patients with Active Psoriatic Arthritis Are Sustained over 2 Years:Long-Term Results of Two Phase 3 Studies with Secukinumab

Authors :: Gossec, L
Kvien, T K
Conaghan, Philip G.
Østergaard, M.
Cañete, J.
Gaillez, C.
Mpofu, S.
Davenport, Emma E
Jugl, S.
Gossec, L
Kvien, T K
Conaghan, Philip G.
Østergaard, M.
Cañete, J.
Gaillez, C.
Mpofu, S.
Davenport, Emma E
Jugl, S.
Source :: Gossec , L , Kvien , T K , Conaghan , P G , Østergaard , M , Cañete , J , Gaillez , C , Mpofu , S , Davenport , E E & Jugl , S 2016 , ' Reduction in Fatigue in Patients with Active Psoriatic Arthritis Are Sustained over 2 Years : Long-Term Results of Two Phase 3 Studies with Secukinumab ' , Annals of the Rheumatic Diseases , vol. 75 , no. Suppl 2 , THU0442 .
Publication Year :: 2016

Database :: OAIster
Journal :: Gossec , L , Kvien , T K , Conaghan , P G , Østergaard , M , Cañete , J , Gaillez , C , Mpofu , S , Davenport , E E & Jugl , S 2016 , ' Reduction in Fatigue in Patients with Active Psoriatic Arthritis Are Sustained over 2 Years : Long-Term Results of Two Phase 3 Studies with Secukinumab ' , Annals of the Rheumatic Diseases , vol. 75 , no. Suppl 2 , THU0442 .
Notes :: English
Publication Type :: Electronic Resource
Accession number :: edsoai.on1322697987
Document Type :: Electronic Resource

Tools